4//SEC Filing
Stellar Biotechnologies, Inc. 4
Accession 0001144204-15-037051
$EDSACIK 0001540159operating
Filed
Jun 14, 8:00 PM ET
Accepted
Jun 15, 6:03 AM ET
Size
5.7 KB
Accession
0001144204-15-037051
Insider Transaction Report
Form 4
MORSE DANIEL E.
Director
Transactions
- Award
Stock Option (Right to Buy)
2015-06-10+25,000→ 25,000 totalExercise: $0.72Exp: 2022-06-10→ Common Shares (25,000 underlying)
Footnotes (2)
- [F1]The options are exercisable at a price of C$0.89. The U.S. dollar price reported on this Form 4 in column 2 reflects the U.S. dollar equivalent exercise price on the date of grant, calculated at the closing price for cable transfers in Canadian dollars as reported by Bloomberg on such date of U.S. $1.00=CDN$1.23
- [F2]One-third of the option vested immediately, one-third of the option vests on the first anniversary of June 10, 2015, and one-third vests 18 months after June 10, 2015.
Documents
Issuer
Stellar Biotechnologies, Inc.
CIK 0001540159
Entity typeoperating
IncorporatedBritish Columbia, Canada
Related Parties
1- filerCIK 0001540159
Filing Metadata
- Form type
- 4
- Filed
- Jun 14, 8:00 PM ET
- Accepted
- Jun 15, 6:03 AM ET
- Size
- 5.7 KB